文献速递骨肌介入DRCTMR

椎体压缩性骨折椎体成形术前行椎体活检的临床价值

Utility of vertebral biopsy before vertebroplasty in patients with diagnosis of vertebral compression fracture.
PubMed 文献 · Radiol Med · 2021-04-12

该回顾性研究纳入1183例无肿瘤或血液病史、影像无继发性骨折可疑征象的椎体压缩性骨折患者,在椎体成形术前对324例进行椎体活检。结论认为活检安全且能发现影响临床管理的意外诊断,建议所有椎体压缩性骨折患者在椎体成形术前进行活检。

要点

  • 椎体成形术前活检在无肿瘤病史患者中可发现6.2%的意外病变。
  • 意外阳性活检中多发性骨髓瘤占60%,淋巴瘤/白血病占25%。
  • 年龄<73岁患者阳性活检发生率显著更高(p=0.01)。

核心结论

  • 椎体活检是安全操作,无相关并发症,在6%的病例中发现意外诊断并影响临床管理。
  • 年轻患者意外阳性组织学发生率显著更高,建议所有椎体压缩性骨折患者在椎体成形术前进行活检。

研究设计与样本

  • 回顾性研究,2003年2月至2019年3月共1183例诊断为椎体压缩性骨折且无肿瘤或血液病史、影像无继发性骨折可疑征象的患者,其中324例在椎体成形术前进行活检。
  • 参考标准为组织学诊断,活检操作依据CIRSE经皮穿刺活检指南。

诊断标准与关键数值

  • 324例活检中9例(2.8%)无法诊断,295例(91%)诊断为骨质疏松,20例(6.2%)组织学阳性提示潜在病变。
  • 20例阳性病例中,多发性骨髓瘤12例(60%),淋巴瘤/白血病5例(25%),脊柱炎1例(5%),转移瘤1例(5%),血管瘤1例(5%)。
  • 年龄<73岁患者阳性活检发生率显著更高(p=0.01),20例阳性活检中17例(85%)为年轻患者。

临床应用与阅片要点

  • 对无肿瘤病史且影像无继发性骨折可疑征象的椎体压缩性骨折患者,椎体成形术前应常规行椎体活检以排除潜在病变。
  • 年轻患者(<73岁)意外阳性率更高,阅片时需更警惕继发性病因,必要时建议活检。

局限性

  • 回顾性研究设计,可能存在选择偏倚。
  • 单中心研究,样本来自特定时间段,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To demonstrate the utility of a biopsy performed just before vertebroplasty in patients with diagnosis of vertebral compression fracture (VCF) and no history of neoplastic or hematologic diseases.

BACKGROUND: Osteoporosis is the most frequent cause of vertebral compression fracture, with trauma and pathologic vertebral weakening being other common causes. Since secondary fractures at imaging investigation can present as simple compression fractures, it is important to identify an underlying pathology. The aim of this paper is to evaluate the frequency of unexpected positive histology in vertebral samples withdrawn from patients undergoing a vertebroplasty to evaluate if a vertebral biopsy can routinely be used in case of VCF and when a secondary cause is not suspected.

METHODS: We retrospectively evaluated the results of 324 biopsies performed from February 2003 to March 2019 just before vertebroplasty in 1183 patients diagnosed with one or more vertebral compression fractures and with no history of neoplastic or hematological diseases and with no suspicious findings for secondary fractures at imaging.

RESULTS: Biopsy was not diagnostic in 9/324 cases (2.8%); osteoporosis was the diagnosis in 295 cases (91%); in the remaining 20 cases (6.2%), histology was positive for an underlying pathology: 12/20 (60% of positive cases) multiple myeloma; 5/20 (25%) lymphoma/leukemia; 1/20 (5%) spondylitis; 1/20 (5%) metastasis; 1/20 (5%) hemangioma. A significantly higher incidence of positive biopsies was found in patients younger than 73 (p = 0.01) with 17 of 20 (85%) positive biopsies. No complications related to the bioptic maneuver were found, according to CIRSE guidelines on percutaneous needle biopsy.

CONCLUSIONS: Vertebral biopsy is a safe procedure with no related complications. In our series, an unexpected diagnosis was found in 6% of cases with impact on patient's clinical management. Positive unexpected histology was significantly higher in younger patients. In conclusion, we believe that a biopsy is useful and should be performed on all patients with vertebral compression fractures before a vertebroplasty.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Sozzi C, Trentadue M, Nicolì L, et al. Utility of vertebral biopsy before vertebroplasty in patients with diagnosis of vertebral compression fracture. Radiol Med. 2021. PMID: 33843004. doi:10.1007/s11547-021-01353-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。